Related Experiment Video
Updated: May 10, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Understanding barriers to glycaemic control from the patient's perspective.
Ron Janes1, Janet Titchener, Joseph Pere
1Wairoa Medical Centre, 24 Kitchener St, PO Box 341, Wairoa, New Zealand. ronjanes@xtra.co.nz
Journal of Primary Health Care
|June 11, 2013
Summary
Understanding patient perspectives is crucial for improving glycaemic control in Type 2 diabetes. Clinicians must address patient fears, beliefs, and contextual factors, rather than solely focusing on biomedical approaches.
Area of Science:
- Medical Sociology
- Endocrinology
- Patient-Centered Care
Background:
- Glycaemic control in Type 2 diabetes is a significant public health challenge.
- Patient-reported barriers are essential for effective diabetes management.
- Existing literature highlights contextual and emotional factors influencing control.
Purpose of the Study:
- To explore patient-identified barriers to achieving glycaemic control.
- To understand the lived experiences of individuals with Type 2 diabetes.
- To inform patient-centered strategies for diabetes care.
Main Methods:
- Interpretative phenomenological analysis of 15 adults with Type 2 diabetes.
- Semi-structured interviews exploring personal experiences with diabetes.
- Thematic analysis organized within a patient-centered framework.
Main Results:
- Barriers include contextual factors (family, finances, work) and negative emotions (fear, guilt, shame).
- Unscientific beliefs, personal beliefs, and poor clinician-patient relationships were significant barriers.
- Patients reported a lack of understanding and a "tell me what to do" approach from clinicians.
Conclusions:
- Clinician awareness of patient fears, beliefs, and context is a key barrier to glycaemic control.
- A shift from a purely biomedical approach to a patient-centered one is necessary.
- Healthcare providers must adapt their approach to improve diabetes care amidst a worsening epidemic and workforce shortages.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:21Barriers to Effective Communication II
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...